Preliminary and Comparative Experiment Study Between 18F-Flurpiridaz and 13N-NH3·H2O Myocardial Perfusion Imaging With PET/CT in Miniature Pigs

1. Go, AS, Mozaffarian, D, Roger, VL, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–152. doi:10.1161/CIR.0b013e318282ab8f
Google Scholar | Crossref | Medline | ISI2. Salata, BM, Singh, P. Role of cardiac PET in clinical practice. Curr Treat Options Cardio Med. 2017;19(12):93. doi:10.1007/s11936-017-0591-x
Google Scholar | Crossref | Medline3. Pan, JA, Salerno, M. Clinical utility and future applications of PET/CT and PET/CMR in cardiology. Diagnostics (Basel). 2016;6(3):32. doi:10.3390/diagnostics6030032
Google Scholar | Crossref4. Werner, RA, Chen, X, Rowe, SP, Lapa, C, Javadi, MS, Higuchi, T. Moving into the next era of PET myocardial perfusion imaging: introduction of novel F-labeled tracers. Int J Cardiovasc Imaging. 2019;35(3):569–577. doi:10.1007/s10554-018-1469-z
Google Scholar | Crossref | Medline5. Berman, DS, Maddahi, J, Tamarappoo, BK, et al. Phase II safety and clinical comparison with single photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F18 positron emission tomography. J Am Coll Cardiol. 2013;61(4):469–477. doi:10.1016/j.jacc.2012.11.022
Google Scholar | Crossref | Medline6. Purohit, A, Radeke, H, Azure, M, et al. Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers. J Med Chem. 2008;51(10):2954–2970. doi:10.1021/jm701443n
Google Scholar | Crossref | Medline7. Maddahi, J, Packard, RR. Cardiac PET perfusion tracers: current status and future directions. Semin Nucl Med. 2014;44(5):333–343. doi:10.1053/j.semnuclmed.2014.06.011
Google Scholar | Crossref | Medline8. Yu, M, Mistry, M, Guaraldi, M, et al. [18F]-RP1012: a novel myocardial perfusion imaging agent for use with positron emission tomography (PET). Circulation. 2005;112(17):II–761.
Google Scholar9. Yu, M, Guaraldi, MT, Mistry, M, et al. BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol. 2007;14(6):789–798. doi:10.1016/j.nuclcard.2007.07.008
Google Scholar | Crossref | Medline10. Maddahi, J, Udelson, J, Heller, GV, et al. The first phase 3 international multicenter clinical trial of Flurpiridaz F18, a new radiopharmaceutical for PET myocardial perfusion imaging (abstract). J Nucl Cardiol. 2015;22:744.
Google Scholar11. Yalamanchili, P, Wexler, E, Hayes, M, et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol. 2007;14(6):782–788. doi:10.1016/j.nuclcard.2007.07.009
Google Scholar | Crossref | Medline12. Yalamanchili, P, Wexler, E, Hayes, M, et al. Mechanism of uptake agent for myocardial imaging using positron emission tomography. Bioorg Med Chem Lett. 2012;22(5):319–322.
Google Scholar | Medline13. Nekolla, SG, Reder, S, Saraste, A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119(17):2333–2342. doi:10.1161/CIRCULATIONAHA.108.797761
Google Scholar | Crossref | Medline14. Leppo, JA, Meerdink, DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 1989;65(3):632–639. doi:10.1161/01.res.65.3.632
Google Scholar | Crossref | Medline15. Schelbert, HR, Phelps, ME, Huang, SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981; 63(6):1259–1272. doi:10.1161/01.cir.63.6.1259
Google Scholar | Crossref | Medline16. Mullani, NA, Goldstein, RA, Gould, KL, et al. Myocardial perfusion with rubidium-82: I—measurement of extraction fraction and flow with external detectors. J Nucl Med. 1983;24(10):898–906.
Google Scholar | Medline17. Maddahi, J, Bengel, F, Huang, S-C, et al. Phase 1 rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: human safety, dosimetry, biodistribution, and myocardial imaging characteristics. J Nucl Med. 2009;50:184.
Google Scholar | Medline18. Huisman, MC, Higuchi, T, Reder, S, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med. 2008;49(4):630–636. doi:10.2967/jnumed.107.044727
Google Scholar | Crossref | Medline19. Higuchi, T, Nekolla, SG, Huisman, MM, et al. A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med. 2008;49(10):1715–1722. doi:10.2967/jnumed.108.053967
Google Scholar | Crossref | Medline20. Sherif, HM, Saraste, A, Weidl, E, et al. Evaluation of a novel 18F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats. Circ Cardiovasc Imaging. 2009;2(2):77–84.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif